本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PMV Pharmaceuticals

1.31
+0.00500.38%
盤後1.310.00000.00%19:30 EDT
成交量:9.45萬
成交額:12.32萬
市值:6,970.71萬
市盈率:-0.93
高:1.32
開:1.30
低:1.30
收:1.31
52周最高:1.88
52周最低:1.02
股本:5,321.15萬
流通股本:4,632.87萬
量比:0.41
換手率:0.20%
股息:- -
股息率:- -
每股收益(TTM):-1.4131
每股收益(LYR):-1.4800
淨資產收益率:-70.93%
總資產收益率:-42.39%
市淨率:0.97
市盈率(LYR):-0.89

資料載入中...

2025/05/09

重要事件披露

Form 8-K - Current report
2025/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/01/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/25

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]